administered with light therapy; expecting results of 2 phase III trials by summer 2010
Brand Aptocine Generic talaporfin
Company name LightSciences Oncology Product type Speciality
Therapeutic category Antineoplastics Key uses hepatocellular carcinoma (HCC), metastatic colorectal cancer (MCRC)
Other Uses benign prostatic hyperplasia (BPH) Drug Class Miscellaneous antineoplastic
Dosage From IV Expected Approval 2012+
FDA Filing N/A Last Update date March 02,2010
Link to pipeline report
Link to news article
Link to clinicaltrials.gov